Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dipyridamole: a critical evaluation.

M P Rivey, M R Alexander, J W Taylor

    Drug Intelligence & Clinical Pharmacy
    |November 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Dipyridamole, a vasodilator, is used as an antiplatelet agent to prevent blood clots. Clinical studies suggest its current value in preventing thromboembolic complications is limited.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Randomised-controlled trials and real-world evidence for optimising TB management.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
    Same author

    <i>Fusarium</i>: more than a node or a foot-shaped basal cell.

    Studies in mycology·2021
    Same author

    Developing immune-regulatory materials using immobilized monosaccharides with immune-instructive properties.

    Materials today. Bio·2020
    Same author

    Which animals are at risk? Predicting species susceptibility to Covid-19.

    bioRxiv : the preprint server for biology·2020
    Same author

    Case of Excision of Hip Joint in Paisley Infirmary: Under the Care of Dr. M'Kinlay.

    Glasgow medical journal·2018
    Same author

    Transcervical aspiration technique for chorion villus biopsy in the first trimester of pregnancy and chromosomal analysis.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2018
    Same journal

    Profile of prescription medication in a pediatric population.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    SI units in drug therapeutics.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Physicians' review of significant interventions by clinical pharmacists in inpatient care.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Possible interaction of ranitidine with phenytoin.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Famotidine-associated mental confusion in elderly patients.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

    Drug intelligence & clinical pharmacy·1988
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Hematology

    Background:

    • Dipyridamole is a vasodilator used clinically as an antiplatelet agent.
    • It was initially developed as an antianginal agent to increase coronary blood flow.
    • Its ability to prolong shortened platelet survival is considered beneficial for preventing thromboembolic complications.

    Purpose of the Study:

    • To review the clinical applications and efficacy of dipyridamole as an antiplatelet agent.
    • To discuss the role of prostaglandins in dipyridamole's action on platelet homeostasis.
    • To evaluate the clinical evidence for dipyridamole, particularly when combined with aspirin.

    Main Methods:

    • Review of existing clinical studies on dipyridamole's use in preventing thromboembolic complications.

    Related Experiment Videos

  • Discussion of dipyridamole's mechanism of action, including its interaction with prostaglandins and platelet aggregation.
  • Analysis of studies combining dipyridamole with aspirin for synergistic anti-aggregatory effects.

    • Main Results:

    • Dipyridamole has been used in conditions with reduced platelet survival, such as heart valve replacement and cerebrovascular disorders.
    • The in vivo effects of dipyridamole on platelet aggregation are not fully understood and may involve other factors.
    • Clinical studies combining dipyridamole with aspirin have not consistently demonstrated added benefit.

    Conclusions:

    • Dipyridamole's role in preventing thromboembolic complications is based on its ability to prolong platelet survival.
    • The precise interaction between dipyridamole and aspirin requires further elucidation.
    • Current clinical evidence suggests that dipyridamole has limited therapeutic value in practice.